Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,015 | 420 | 96.9% |
| Education | $316.64 | 11 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,712 | 121 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,834 | 95 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $721.73 | 35 | $0 (2023) |
| Grifols USA, LLC | $604.52 | 24 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $403.30 | 10 | $0 (2024) |
| Shire North American Group Inc | $355.43 | 18 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $355.15 | 9 | $0 (2021) |
| ABBVIE INC. | $345.76 | 20 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $298.96 | 27 | $0 (2019) |
| Amgen Inc. | $213.25 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $910.79 | 23 | AstraZeneca Pharmaceuticals LP ($352.78) |
| 2023 | $753.78 | 19 | GlaxoSmithKline, LLC. ($186.51) |
| 2022 | $1,782 | 42 | AstraZeneca Pharmaceuticals LP ($999.21) |
| 2021 | $1,661 | 54 | AstraZeneca Pharmaceuticals LP ($982.70) |
| 2020 | $1,421 | 59 | AstraZeneca Pharmaceuticals LP ($852.59) |
| 2019 | $875.49 | 48 | Shire North American Group Inc ($191.69) |
| 2018 | $1,342 | 82 | GlaxoSmithKline, LLC. ($299.80) |
| 2017 | $1,585 | 104 | GlaxoSmithKline, LLC. ($394.77) |
All Payment Transactions
431 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $80.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Pulmonology | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $102.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Pulmonology | ||||||
| 09/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Pulmonology | ||||||
| 06/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Pulmonology | ||||||
| 04/05/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Pulmonology | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $102.21 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $81.41 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Inflammation | ||||||
| 11/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $139.29 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 459 | 501 | $54,545 | $19,365 |
| 2022 | 7 | 563 | 602 | $65,295 | $24,132 |
| 2021 | 10 | 1,046 | 1,106 | $171,294 | $54,929 |
| 2020 | 11 | 2,211 | 2,651 | $409,259 | $126,315 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 116 | $26,638 | $10,203 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $15,036 | $4,907 | 32.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 17 | 17 | $4,647 | $1,613 | 34.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 103 | 103 | $2,759 | $937.36 | 34.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 108 | 108 | $3,053 | $844.43 | 27.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 103 | 103 | $2,053 | $700.20 | 34.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 11 | $358.05 | $159.70 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 114 | $26,179 | $10,543 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $18,183 | $6,460 | 35.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 35 | 36 | $9,841 | $3,416 | 34.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 127 | 128 | $3,429 | $1,222 | 35.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 128 | 129 | $3,647 | $1,060 | 29.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 127 | 128 | $2,551 | $912.81 | 35.8% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 15 | 15 | $1,466 | $518.16 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 382 | 441 | $76,503 | $28,104 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 149 | 149 | $46,269 | $14,842 | 32.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 122 | 123 | $13,032 | $4,742 | 36.4% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 38 | 38 | $10,459 | $3,068 | 29.3% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 125 | 125 | $8,435 | $1,077 | 12.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 20 | 20 | $4,423 | $1,048 | 23.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 127 | 127 | $8,705 | $941.03 | 10.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 12 | $1,826 | $435.36 | 23.8% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 52 | 52 | $1,036 | $388.44 | 37.5% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 19 | 19 | $605.35 | $281.94 | 46.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 759 | 1,142 | $188,595 | $65,740 | 34.9% |
About Dr. Nelson Yu, MD
Dr. Nelson Yu, MD is a Pulmonary Disease healthcare provider based in Granite City, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447297601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nelson Yu, MD has received a total of $10,332 in payments from pharmaceutical and medical device companies, with $910.79 received in 2024. These payments were reported across 431 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,015).
As a Medicare-enrolled provider, Yu has provided services to 4,279 Medicare beneficiaries, totaling 4,860 services with total Medicare billing of $224,741. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine
- Location Granite City, IL
- Active Since 05/31/2006
- Last Updated 05/23/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447297601
Products in Payments
- BREZTRI (Drug) $1,279
- SYMBICORT (Drug) $985.28
- FASENRA (Biological) $732.26
- GLASSIA (Biological) $710.58
- TRELEGY ELLIPTA (Drug) $673.29
- NUCALA (Biological) $615.79
- DUPIXENT (Biological) $542.59
- Prolastin-C Liquid (Biological) $284.54
- BREO (Drug) $217.36
- FARXIGA (Drug) $207.84
- AIRSUPRA (Drug) $201.40
- UTIBRON (Drug) $197.13
- Arikayce (Drug) $189.92
- STIOLTO (Drug) $176.21
- Mavyret (Drug) $168.28
- SPIRIVA RESPIMAT (Drug) $140.74
- AREXVY (Drug) $121.48
- ANORO (Drug) $114.42
- Xembify (Biological) $111.91
- Prolastin-C (Biological) $111.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.